Hepatitis B vaccine recombinant (sanofi pasteur)

重组乙型肝炎疫苗(赛诺菲巴斯德)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B vaccine recombinant (sanofi pasteur)
Drug Alias NameHBvaxPRO
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2001/04/27
Country/TerritoryFinlandEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme Bv
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ07BC01
Related LinksN/A